This conversation will critically examine the role of AI-augmented tools to support pharmacists’ clinical reasoning in the complex world of deprescribing. Through real-world scenarios, participants will examine how artificial intelligence can support medicine reviews, flag deprescribing opportunities, and guide safer conversations with prescribers, patients, and families. We’ll unpack the limitations, ethical considerations, and practical pathways for integrating these technologies into everyday workflow - without losing the human element. Whether you're tech-curious or already piloting digital tools, come prepared to challenge assumptions and reimagine deprescribing through an AI-informed lens.
This conversation session will address the following learning objectives:
Michael Bakker FANZCAP (Informtcs), Chief Pharmacist Information Officer, SA Pharmacy, Adelaide, SA
Dr Emily Reeve Senior Research Fellow and Deputy Theme Lead of the Centre for Medicine Use and Safety, Monash University and Chair, Australian Deprescribing Network, Melbourne, Vic
Dr Amy Nguyen Senior Research Fellow, The Australian Institute of Health Innovation, Macquarie University, Sydney, NSW
Rachael Worthington Patient Safety and Clinical Benefits Lead, eHealth NSW, Sydney, NSW